Transcutaneous grass specific immunotherapy is an alternative to traditional treatment in controlling allergic rhinoconjunctivitis.
Grass transcutaneous immunotherapy in children with seasonal rhinoconjunctivitis
Article first published online: 5 OCT 2009
© 2009 John Wiley & Sons A/S
Volume 65, Issue 3, pages 410–411, March 2010
How to Cite
Agostinis, F., Forti, S. and Di Berardino, F. (2010), Grass transcutaneous immunotherapy in children with seasonal rhinoconjunctivitis. Allergy, 65: 410–411. doi: 10.1111/j.1398-9995.2009.02189.x
- Issue published online: 3 FEB 2010
- Article first published online: 5 OCT 2009
- Accepted for publication 27 July 2009
- 4Committee for Medicinal Products for Human Use (CHMP) and Efficacy Working Party (EWP): Concept Paper on the preparation of a guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases. In: 18504/2006: EMEA/CHMP/EWP; 2006.